Literature DB >> 18520782

Treatment outcome for adolescent obsessive-compulsive disorder in a specialized hospital setting.

Thröstur Björgvinsson1, Chad T Wetterneck, Dana M Powell, Gregory S Chasson, Sarah A Webb, John Hart, Susan Heffelfinger, Renee Azzouz, Terri L Entricht, Joyce E Davidson, Melinda A Stanley.   

Abstract

Although few data are available concerning adolescents with obsessive-compulsive disorder (OCD), the existing literature suggests that cognitive-behavioral therapy (CBT) is the first-line treatment of choice for adolescents with mild to moderate OCD. A combination of CBT and serotonin reuptake inhibitors (SRIs) is recommended for more severe forms of OCD, based on the Expert Consensus Guidelines for the Treatment of Obsessive-Compulsive Disorder and the Pediatric OCD Treatment Study (POTS). Despite the effectiveness of CBT, a recent meta-analysis found that 27% of adolescent outpatients fail to show clinically significant improvement following CBT and many also fail to show improvement with pharmacotherapy. One alternative for those who do not improve with outpatient treatment is an intensive inpatient program. Within the last 10 years, two specialty hospitals have created programs that provide intensive CBT milieu treatment with multidisciplinary support (e.g., nursing, psychopharmacology) to treat adolescents with OCD. This naturalistic study describes treatment outcomes in 23 patients who received treatment in one of these programs between 2005 and 2006. Results suggest significant improvements on the majority of outcome measures, with 70% of the patients judged to meet criteria for clinically significant change. Thus, inpatient treatment appears potentially efficacious, although future controlled trials with larger samples are needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520782     DOI: 10.1097/01.pra.0000320112.36648.3e

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  7 in total

1.  Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response.

Authors:  Brian P Brennan; Catherine Lee; Jason A Elias; Jesse M Crosby; Brittany M Mathes; Marie-Christine Andre; Christina M Gironda; Harrison G Pope; Michael A Jenike; Garrett M Fitzmaurice; James I Hudson
Journal:  J Psychiatr Res       Date:  2014-05-23       Impact factor: 4.791

Review 2.  Evidence base update for psychosocial treatments for pediatric obsessive-compulsive disorder.

Authors:  Jennifer Freeman; Abbe Garcia; Hannah Frank; Kristen Benito; Christine Conelea; Michael Walther; Julie Edmunds
Journal:  J Clin Child Adolesc Psychol       Date:  2013-06-09

3.  Residential treatment outcomes for adolescents with obsessive-compulsive disorder.

Authors:  Rachel C Leonard; Martin E Franklin; Chad T Wetterneck; Bradley C Riemann; H Blair Simpson; Kimberly Kinnear; Shawn P Cahill; Peter M Lake
Journal:  Psychother Res       Date:  2015-08-26

4.  Latinos with obsessive-compulsive disorder: Mental healthcare utilization and inclusion in clinical trials.

Authors:  Chad T Wetterneck; Tannah E Little; Kimberly L Rinehart; Maritza E Cervantes; Emma Hyde; Monnica Williams
Journal:  J Obsessive Compuls Relat Disord       Date:  2012-01-08       Impact factor: 1.677

5.  Assessment and medication management of paediatric obsessive-compulsive disorder.

Authors:  S Evelyn Stewart; Dianne Hezel; Andrea C Stachon
Journal:  Drugs       Date:  2012-05-07       Impact factor: 9.546

Review 6.  Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents.

Authors:  R T O'Kearney; K J Anstey; C von Sanden
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

7.  Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial.

Authors:  Gudmundur Skarphedinsson; Bernhard Weidle; Per Hove Thomsen; Kitty Dahl; Nor Christian Torp; Judith B Nissen; Karin Holmgren Melin; Katja Hybel; Robert Valderhaug; Tore Wentzel-Larsen; Scott N Compton; Tord Ivarsson
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-09-20       Impact factor: 4.785

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.